Allergie Weg SRL
Allergie Weg reported total assets of 114,157 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).
The score of Allergie Weg shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -30 % Total assets +52 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Allergie Weg's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 37,532 € | ||||
| Equity | 31,800 € | ||||
| Cash | 96,430 € | ||||
| EBITDA | 54,427 € | ||||
| Total assets | 114,157 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
- Year ended 31 Dec 2024filed on 19 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jun 2024
- Year ended 31 Dec 2022filed on 18 Aug 2023
- Year ended 31 Dec 2021filed on 30 Jul 2022
Allergie Weg's financial analysis
- Solvency27.9%sector median: 56.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Allergie Weg
Allergie Weg's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0736.609.189
- VAT number
- BE0736609189
- Peppol
- Registered · 0208:0736609189 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Oct 2019
- Registered office
- 9800 Deinze
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Public relations and communication activities (NACE 73300)
Allergie Weg (SRL) has been based in Deinze since 2019, active in: public relations and communication activities. For 2025, it reports a net profit of 37,532 € and equity of 31,800 €; its revenue is not published. Its solvency stands at 27.9%, below the median of its sector (56.8%).
Companies similar to Allergie Weg
Companies in the same business, of comparable size and area, outside its group.
- Delta Towards Excellence Public relations and communication activities Overijse · balance sheet 36,825 €
- RDLJ Public relations and communication activities Hannut · balance sheet 111,373 €
- TOOT Public relations and communication activities Antwerp · balance sheet 120,968 €
- D2P Public relations and communication activities Braine-l'Alleud · balance sheet 101,040 €
- All-Ro Act Public relations and communication activities Bonheiden · balance sheet 115,625 €
- Tesoro Public relations and communication activities Olen · balance sheet 73,129 €
- Words & Wines Public relations and communication activities Vilvoorde · balance sheet 155,732 €
- The C Company Public relations and communication activities Uccle · balance sheet 19,715 €
Frequently asked questions about Allergie Weg
What is the revenue of Allergie Weg?
Allergie Weg files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Allergie Weg?
In Belgium, the VAT number is the company number prefixed with BE: BE0736609189 for Allergie Weg, if the company is VAT-registered. Its company number (CBE) is 0736.609.189.
Where is the registered office of Allergie Weg?
According to the CBE register, the registered office of Allergie Weg is in 9800 Deinze.
What is the equity of Allergie Weg?
At the close of the 2025 financial year, the equity of Allergie Weg amounts to 31,800 €, a solvency of 27.9% of total assets.
Who manages Allergie Weg?
The register lists 1 active mandates at Allergie Weg. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Allergie Weg
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →